Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia

Medical Mycology

Volumn 48, Issue 5, 2010, Pages 704-709

  Choi, Jung Hyun ^a   Kwon, Eun Young ^b   Park, Chul Min ^b   Choi, Su Mi ^a   Lee, Dong Gun ^a   Yoo, Jin Hong ^a   Shin, Wan Shik ^a   Stevens, David A ^c,d,e  

^a Department of Medicine   (United States)

^b The Catholic University of Korea   (South Korea)

^c SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^d CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antifungals; GM CSF; Immunomodulation; TNF

Indexed keywords

AMPHOTERICIN B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICAFUNGIN; TUMOR NECROSIS FACTOR ALPHA; VORICONAZOLE; ANTIFUNGAL AGENT; ECHINOCANDIN; IMMUNOLOGIC FACTOR; LIPOPEPTIDE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL VIABILITY; CONCENTRATION RESPONSE; CONIDIUM; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; MONOCYTE; NONHUMAN; POLYMERASE CHAIN REACTION; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; FUNGUS SPORE; IMMUNOLOGY; MICROBIOLOGY; SECRETION (PROCESS);

ASPERGILLUS FUMIGATUS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CELL LINE; CELL SURVIVAL; ECHINOCANDINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOLOGIC FACTORS; LIPOPEPTIDES; MONOCYTES; PYRIMIDINES; SPORES, FUNGAL; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VORICONAZOLE;

EID: 77954789442     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903471784     Document Type: Article

References (29)

1. Labro MT. Antibacterial agents-phagocytes: new concepts for old in immunomodulation. Int J Antimicrob Agents 1998; 10 : 11-21.
2. Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev 2000; 13 : 615-650.
3. Shalit I, Kletter Y, Halperin D, et al . Immunomodulatory effects of moxifl oxacin in comparison to ciprofl oxacin and G-CSF in a murine model of cyclophosphamide induced leukopenia. Eur J Haematol 2001; 66 : 287-296.
4. Jun YT, Kim HJ, Song MJ, et al . In vitro effects of ciprofl oxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Antimicrob Agents Chemother 2003; 47 : 1161-1164.
5. Khan AA, Slifer TR, Remington JS. Effect of trovafl oxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 1998; 42 : 1713-1717.
6. Riesbeck K, Forsgren A, Henriksson A, Bredberg A. Ciprofl oxacin induces an immunomodulatory stress response in human T lymphocytes. Antimicrob Agents Chemother 1998; 42 : 1923-1930.
7. Tohru K, Koichi H, Yoshihiro H, e t al . Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kB transcription factors. J Antimicrob Chemother 2002; 49 : 745-755.
8. Simitsopoulou M, Roilides E, Paliogianni F, e t al . Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus : differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52 : 3301-3306.
9. Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates infl ammatory responses to Aspergillus fumigatus through stagespecific effects on fungal beta-glucan exposure. J Infect Dis 2008; 198 : 176-185.
10. Lamaris GA, Lewis RE, Chamilos G, e t al . Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198 : 186-192.
11. Stevens DA. Combination immunotherapy and antifungal chemotherapy. Clin Infect Dis 1998; 26 : 1266-1269.
12. Choi JH, Song MJ, Kim SH, e t al . Effect of moxifl oxacin on production of proinfl ammatory cytokines from human peripheral blood mononuclear cells. Antimicrob Agents Chemother 2003; 47 : 3704-3707.
13. Kwon EY, Park CM, Park SH, et al. Effects of antifungal agents on the production of cytokines from macrophages stimulated by Aspergillus fumigatus conidia. Infect Chemother 2007; 39 : 38-45.
14. Choi JH, Brummer E, Kang YJ, Jones PP, Stevens DA. Inhibitor kB and nuclear factor kB in granulocyte and macrophage colonystimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia. J Infect Dis 2006; 193 : 1023-1028.
15. Stevens DA. Th1/Th2 in aspergillosis. M ed Mycol 2006; 4 4 : S229-235.
16. Yano T, Teruya K, Shirahata S, e t al . Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 1994; 16 : 167-178.
17. Kim JY, Ro JY. Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate actetate-stimulated HMC-1 cells. Scand J Immunol 2005; 62 : 25-35.
18. Rex JH, Stevens DA. Systemic antifungal agents. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease , 6th edn. Philadelphia: Churchill and Livingstone, 2005: ch. 37.
19. Gartner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24 : 1277-1286.
20. Stevens DA. A possible mechanism for synergy between antifungal therapy and immune defense. J Infect Dis 2008; 198 : 159-162.
21. Rivera A, Van Epps HL, Hohl TM, Rizzuto G, Pamer EG. Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun 2005; 73 : 7170-7179.
22. Sau K, Mambula SS, Latz E, et al . The antifungal drug amphotericin B promotes infl ammatory cytokine release by a Toll-like receptor-and CD14-dependent mechanism. J Biol Chem 2003; 278 : 37561-37568.
23. Razonable RR, Henault M, Lee LN, et al . Secretion of proinfl ammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of Toll-like receptor 1 and 2. Antimicrob Agents Chemother 2005; 49 : 1617-1621.
24. Kinoshita K, Iwasaki H, Uzui H, Ueda T. Candin family antifungal agent micafungin (FK463) modulates the infl ammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells. Transl Res 2006; 148 : 207-213.
25. Marr KA, Balajee SA, Hawn TR, e t al . Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 2003; 71 : 5280-5286.
26. Netea MG, Van der Graaf C, Van der Meer JWM, Kullberg BJ. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 2004; 23 : 672-676.
27. Bellocchio S, Montagnoli C, Bozza S, et al . The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo . J Immunol 2004; 172 : 3059-3069.
28. Braedel S, Radsak M, Einsele H, e t al . Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptor 2 and 4. Br J Haematol 2004; 125 : 392-399.
29. Brummer E, Maqbool A, Stevens DA. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. Med Mycol 2001; 39 : 509-515.